Patent · US Expired

Cytoprotective compounds

US6423855B1 · kind B1 · utility

1Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2000
Grant dateJul 23, 2002
Priority date
Expiry dateJan 12, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C309/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting phospholipase mediated injury, injury due to oxidation, and inflammation. In a very specific sense, this invention provides compositions and methods of making these compositions that are inhibitors of phospholipase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.